Purchase Order 75N95025P00391
Award Date
9/9/25
Potential Completion Date
10/8/25
Potential Value
$25K
Federal Agency
National Institute on Drug Abuse
Awardee
Cell Signaling Technology, Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21224, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. government, to Cell Signaling Technology, Inc., a private, for-profit manufacturer of research products. The $13,220.05 firm fixed-price purchase order is for the provision of antibodies and reagents for Western blot analysis, designated as AMBIS 2261414 - CELL TECHNOLOGIES. The award does not have a set-aside designation, indicating Cell Signaling...
This federal contract award was made by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Life Technologies Corporation, a for-profit manufacturer of scientific instruments, reagents, and consumables. The $91,545.00 firm fixed-price purchase order is for the delivery of assorted cell consumables. The contract has no set-aside designation. Life Technologies Corporation, a division of Thermo Fisher Scientific, has...
This is a $99,715.40 firm fixed-price purchase order awarded to Cisbio US, Inc., a foreign-owned for-profit company, by the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services (HHS). The contract is for the provision of assay kits, cell lines, and collagen reagents to support research activities. This award was not set aside and is the latest in a series of similar purchase orders awarded to Cisbio US, Inc. to provide biomarker...
This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Antibodies Incorporated, a small business manufacturer and distributor of antibodies, diagnostics, and laboratory services. The $29,292.00 contract is for the provision of KDEL receptor antibodies, which are used in biomedical research. This award was issued under a total small business set-aside solicitation, and Antibodies...
This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the National Institutes of Health, to Med Associates, Inc., a for-profit, woman-owned small business manufacturer and supplier of specialized scientific laboratory equipment and software. The contract award, valued at $18,898.50, is for the delivery of products that support research into substance use disorders, neurological processes, addiction mechanisms, and behavioral...
This is a $78,489 firm fixed-price purchase order award to Government Scientific Source Inc. by the National Institute on Drug Abuse (NIDA) for the 10X Genomics Chromium Single Cell Multiome ATAC + Gene Expression Reaction Kits and associated maintenance and service plan. The award was made on a sole-source, non-competitive basis under simplified acquisition procedures. The kits will be used by NIDA's Chittiboina Lab to study the pathology and cell interactions within tumors related to Cushing's...
This is a $60,701.56 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the U.S. Department of Health and Human Services. The award was made to Agilent Technologies Inc., a manufacturer of scientific instruments and equipment. The contract has no set-aside designation. The award is for the provision of unspecified products and services by Agilent's Customer Service and Sales Division. Agilent is a major supplier of analytical...
<p>The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $24,900 firm fixed price purchase order contract to Pelago Bioscience AB, a for-profit limited liability company. The contract is for the development of a new assay to test compounds of interest. The period of performance runs from the award date of September 9, 2024 through September 8, 2025. This contract award does not have a set-aside designation.</p>
The Department of Health and Human Services' National Institutes of Health's National Institute on Drug Abuse awarded a $24,825 purchase order to Sigma-Aldrich, Inc. for contract 1107546 under contract number 23-005532. Performance will take place in Baltimore, Maryland over the course of one year beginning in September 2023. The firm fixed price contract is for the procurement of products or services to support NIH/NIDA research efforts, though details of the work were not provided....
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Cell Signaling Technology, Inc., a private company based in Danvers, Massachusetts. The contract, valued at $24,000.00, is for the provision of specialized "PhosphoScan" research services. The contract has a period of performance from September 10, 2014, to September 30, 2015, and was not set aside for any particular type of business. Cell Signaling Technology, Inc. is a for-profit...